Go to contents
Go to menu
°Ë»ö¾î ÀÔ·Â
Ȩ
·Î±×ÀÎ
Áñ°Üã±âÃß°¡
ENGLlSH
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Îº°°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
ÇÐȸ/Çùȸ Á¤º¸
Àú³Î Á¤º¸
Àú³Î Åõ°í ±ÔÁ¤
KMbase ¼Ò°³
°øÁö»çÇ×
¾÷µ¥ÀÌÆ® Á¤º¸
³» Á¤º¸
ÀúÀå ³í¹®
°ü½ÉºÐ¾ß ³í¹®
°ü½ÉÇÐȸ/ÇмúÁ¤º¸
¿ø¹®½Åû
°ü½ÉºÐ¾ß °ü¸®
½ºÅ©¸³Æ® ȯ°æ¿¡¼ Áö¿øµË´Ï´Ù.
³í¹®°Ë»ö
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Î°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
SITE LINK
PubMed
Google Scholar
KoreaScience
NDSL
KoreaMed
RISS
MEDLIS
Cross Check
´ëÇѺñ´¢±â°úÇÐȸÁö
( Korean Journal of Urology )
: °Ë»ö°á°ú :
19
  
°Ë»ö°á°ú¸ðµÎ¼±ÅÃ
1
¿äµµÇÏ¿ÀÇ Megameatus Intact Prepuce Variant 1·Ê
A Case of Megameatus Intact Prepuce Hypospadias Variant
ÀÌÁö¿
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 328 ~ 334
2
¿ø¹ß¼º ¸¸¼º °¡¼º ÀåÆó»öÁõÈıºÀ» µ¿¹ÝÇÑ °Å´ë¹æ±¤ÀÇ º´¿ø·Ê
A Case of Megacystis Associated with Primary Chronic Intestinal
¼Õµ¿¿Ï
ÀÌ»óµ·/ÀÌÁ¤ÁÖ/¹ÚÀçÈ«/À±Á¾º´
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 323 ~ 327
3
½Åµ¿¸Æ·ù¸¦ µ¿¹ÝÇÑ ÀÚ¿¬ÆÄ¿µÈ ¼±Ãµ¼º ½Åµ¿Á¤¸Æ ±âÇü 1·Ê
Spontaneously Ruptured Congenital Arteriovenous malformation of Kidney with Renal Artery Aneurysm: A
...
¼ÕÁ¤È£
¾ÈÇö¼ö/Á¤µµ¿µ/±è¼¼Áß/±è¿µ¼ö/¿Àâ±Ç/ÁøÀ±¹Ì
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 319 ~ 322
4
ºÎ½Å ¿Ü °¥»ö¼¼Æ÷Á¾ 1·Ê
A Case of Extra-adrenal Pheochromocytoma
Á¤Ã¢¼ö
¹ÚÁØŹ/À±¿µÈ/±è¼øÂù/³²»ï±Ø
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 315 ~ 318
5
ÃÊÀ½ÆÄÃÔ¿µÀ¸·Î ¹ß°ßµÈ °íȯ¹Ì¼®Áõ
Sonographically Detected Testicular Microlithiasis
±ÇÀçÀÏ
±è¼¼Áß, ±è¿µ¼ö
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 312 ~ 314
6
¹ß±âÀ¯¹ßÁ¦ÀÇ À½°æÇظéü³» ÀÚ°¡ÁÖ»ç¿ä¹ý: Bimix¿Í TrimixÈ¥Çվ׿¡ ÀÇÇÑ ¹ß±â¹ÝÀÀ ¹× ÇÕº´ÁõÀÇ ºñ±³ºÐ¼®
Intracavernosal Self-Injection Therapy for the Patients with Erectile Dysfunction: Comparison of Ere
...
¼°æ±Ù
¼Û±â±Ù, Á¶¿ë°ü
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 306 ~ 311
7
¼ººÐÈȯÀÚ¿¡¼ÀÇ SRY À¯ÀüÀÚ°Ë»ö
SRY Gene Evaluation in Patients with the Disorders of Sexual Differentiation
À̹ÎÁ¾
ÇÑ»ó¿ø, ±èÀüÈ£, ±èÁØ»ó
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 299 ~ 305
8
Trocar¸¦ ÀÌ¿ëÇÑ Ä¡°ñ»óºÎ¹æ±¤·çÁ¶¼º¼ú½Ã ÃÊÀ½ÆÄ °Ë»çÀÇ À¯¿ë¼º
Efficacy of the Preliminary Ultrasonographic Examination before Suprapubic Cystostomy by Trocar
±èÀçÈ«
¼®ºÀö, ¾ç½ÂÇÐ
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 295 ~ 298
9
º¹¾Ð¼º ¿ä½Ç±Ý ȯÀÚ¿¡¼ ÁúÀ» ÅëÇÑ Burch ¼ú½ÄÀÇ Ãʱâ°æÇè
Early Experience of the Transvaginal Burch Bladder Neck Suspension for Female Stress Urinary Inconti
...
ÀÌÀç¿ø
±èµ¿¿í, À±¼®Áß, ±èµ¿±Ô
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 289 ~ 294
10
Pressure Transmission Ratio´Â º¹¾Ð¼º ¿ä½Ç±Ý ȯÀÚ¿¡¼ ¼ö¼ú¼º°øÀÇ ÁÁÀº ÁöÇ¥Àΰ¡?
Is Pressure-Transmission Ratio in Genuine Stress Urinary Incontinence a Good Parameter of Success af
...
±è¿µÃ¶
¼ÁÖÅÂ, ÀÌÀ¯½Ä
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 283 ~ 288
11
Àü¸³¼±ºñ´ëÁõ¿¡ µ¿¹ÝµÈ ºÒ¾ÈÁ¤¼º ¹æ±¤ÀÇ TURPÀüÈÄ ÀÓ»ó ¹× ¿ä¿ªµ¿ÇÐÀû ´Ü°¡ÀÇ ÀÇÀÇ
The Influence of TURP on detrusor Instability in Patients with BPH: A Clinical and Urodynamic Analys
...
À庴ÁØ
Çϸ¸±¤, ±èÅÂÁ¾
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 275 ~ 282
12
Àü¸³¼± ƯÀÌÇ׿ø ÃøÁ¤ ÀüÈıâÀÇ Àü¸³¼±¾ÏÀÇ 10³â°£ ÀÓ»óÀû ¾çÅÂ
The Change of clinical Characteristics of Prostatic Cancer before and after the Introduction of Pros
...
º¯¼®¼ö
Á¶±Ô¼±/¼¼ºÀÏ/¿À½ÂÁØ/Á¤Áø¼ö/ÀÌ»óÀº
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 270 ~ 274
13
¹æ±¤¾ÏȯÀÚ¿¡¼ Basic Fibroblast Growth Factor¹ßÇöÀÇ ÀÓ»óÀû ÀÇÀÇ
Clinical Significance of Basic Fibroblast Growth Factor Expression in Bladder Cancer
³ëº¸»ó
¸í¼øö, ·ùÈñ¼ö
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 263 ~ 269
14
¹æ±¤ ÀÌÇà»óÇÇ¾Ï Ç¥½ÄÀڷμ ¿äÁß Nuclear Matrix protein (NMP) ÀÇÀÇ
The Significance of Urinary Nuclear Matrix Protein (NMP) as a Marker for Transitional Cell Carcinoma
...
±èÁß¼ö
ÀÌ°Çö, ÀÌÇö¹«
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 259 ~ 262
15
¹æ±¤ÀüÀûÃâ¼úÀ» ½ÃÇàÇÑ ¹æ±¤ÀÌÇà»óÇǼ¼Æ÷¾ÏȯÀÚ¿¡¼ ¿¹ÈÄÀÎÀڷμ P53 ´Ü¹éÁú °ú¹ßÇöÀÇ ÀÇÀÇ
The Significance of the P53 Protein Overexpression as a Prognostic Marker in Transitional Cell Carci
...
ÀüÁø¼ö
±è¼ö¿õ, ÃÖ¼÷
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 250 ~ 258
16
¿ì¿¬È÷ ¹ß°ßµÈ ½ÅÁ¾¾çÀÇ ÀÓ»óÀû Ư¼º
Clinical Characteristics of Incidentally Detected Renal Cell Carcinoma
¼ººÀ¸ð
±èµ¿¼±, ¹é¾ÇÁÖ
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 245 ~ 249
17
¿ä°ü °á¼®¿¡ ÀÖ¾î¼ Swiss LithoclastÀÇ Ãʱâ ÀÓ»ó°æÇè
Initial Clinical Experience of the Swiss Lithoclast in Ureteral stone
¾È¼º¼ö
±è±Ôȯ, ¿À°æÁØ
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 241 ~ 244
18
ºñ°ü»óÇü ȸÀå¹æ±¤¼ºÇü¼ú°ú °ü»óÇü ȸÀå¹æ±¤¼ºÇü¼úÀ» ½ÃÇàÇÑ ÁÖÀÇ È¸ÀåºÐÀý¿¡¼ ¼öÃà¹ÝÀÀ ¹× Á¶Á÷ÇÐÀû º¯È
...
The Pharmocological and Histological Comparison Between Detubularized and Tubularized Cystoplasty Il
...
À̼ÇÐ
º¹Á¾¹Î, ¾È¸íÀÚ, ÃÖâÁø
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 235 ~ 240
19
Á¾¾ç±«»çÀÎÀÚ À¯ÀüÀÚÀÌÀÔ ¹æ±¤ÀÓ ¼¼Æ÷ÁÖ¿¡¼ ¼¼Æ÷¼ºÀå°ú ÀÌÀÔµÈ À¯ÀüÀÚ ¹ßÇö¿¡ ¹ÌÄ¡´Â Retinoic AcidÀÇ ¿µ
...
Effect of Retinoic Acid on Growth and Transduced Tumor Necrosis Factor-¥á Gene Expression of Human B
...
Á¤Çö
À±»óÁø/Á¶¹®±â/ÀÌÇØ¿ø/±è¼ö¿õ/ÀÌÀº½Ä/ÀÌÁ¾¿í
´ëÇѺñ´¢±â°úÇÐȸÁö
1997³â 38±Ç 3È£ 229 ~ 234